Drupal.behaviors.print = function(context) {window.print();window.close();}>
Epigenomics Posts 6 Percent Q3 Revenues Increase, Eyes FDA Submission for Colorectal Cancer Test by Year End
November 07, 2012
Epigenomics Posts 6 Percent Q3 Revenues Increase, Eyes FDA Submission for Colorectal Cancer Test by Year End
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Epigenomics' Q2 Revenues Tumble 57 Percent
August 8, 2012 / GenomeWeb Daily News
Epigenomics' Q1 Revenues Fall 67 Percent
May 9, 2012 / GenomeWeb Daily News
Epigenomics' Q3 Revenues Fall 29 Percent; PMA Submission Targeted for Epi proColon 2.0
November 9, 2011 / GenomeWeb Daily News
Epigenomics' First-Half Revenues Inch Up; Firm Will Cut Staff in Restructuring Effort
August 10, 2011 / GenomeWeb Daily News
Epigenomics' Nine-Month Revenues Drop Sharply
November 9, 2010 / GenomeWeb Daily News